The Magazine for Sleep Professionals
Thursday, April 23, 2026
Inspire Medical Systems, Inc. announced that the United States Food and Drug Administration (FDA) has approved additional magnetic resonance imaging (MRI) scan conditions for use with Inspire therapy. This full-body MRI approval expands the Inspire use labeling that previously allowed only head, neck, and extremity MRI scans. Most importantly, this […]
Two-incision approach reduces average procedure time by approximately 20 percent Inspire Medical Systems, Inc. has announced receipt of U.S. Food and Drug Administration (“FDA”) approval for an improved surgical implant procedure that eliminates one incision with a revised placement of the pressure sensing lead. This newly approved procedure will reduce […]
Inspire Medical Systems, Inc. (“Inspire”) announced today that Cigna, one of the leading health plans in the United States, will provide coverage for the Company’s Inspire therapy (hypoglossal nerve neurostimulation), effective June 15, 2020. Cigna Corporation is a global health service company that provides health insurance coverage for approximately 16 […]
